Catalyst Wire Dossier Catalyst Wire Dossier

Lexiscan

regadenoson · Astellas Pharma US, Inc.
Drug timelines are a Plus or Pro feature.

35 regulatory and trial events tracked for Lexiscan, covering 2008-04-10 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients [Phase 1, Phase 2]

See pricing